News Digest #232 – Rewriting DNA with enzymatic synthesis + today’s report and webinar on chemicals and materials (sponsored by Molecular Assemblies)

 

 


Hi all,The SynBioBeta 2018 Early Bird is ending August 31st. If you want to see a sample of who’s coming to do business then check it out here.

Today at 10 a.m. Pacific, we’ll be announcing the first of five special SynBioBeta reports on how synthetic biology is transforming long-established industry sectors. The first will be on chemicals and materials. Register here to download the report and join the webinar.

My book “What’s your bio strategy?” was just reviewed by Labiotech.eu, who called it a “great perspective on why synbio could impact the global economy as the digital technologies did”.

This week, we interviewed Michael Kamdar and Bill Efcavitch of Molecular Assemblies about why they believe enzymatic DNA synthesis will open doors to new technologies and breakthroughs for our future. The technology could someday enable researchers to make gene-sized pieces of DNA in a single reaction. Mike is sponsoring the “Future of DNA Synthesis” panel discussion at SynBioBeta again this October.

Ignacio Willats, who will be speaking at SynBioBeta 2018, announced that his lab automation company HackScience is now called Cytera CellWorks, and it will focus on the automation of cell cultures for the food industry. Locus BioSciences, which acquired EpiBiome last month, is moving into more lab space to ramp up the development of CRISPR-Cas3 antibacterial products. Thomas Meany from Open Cell recently welcomed their first tenants that break the boundaries between biology, design, and technology: Chips board, Biohm, ByBi beauty, Olombria, WASE, Alice Potts. He also announced a new London Design Festival event “Biodesign Here Now” that they are hosting on September 15-23.

Check out our speakers, schedule, and register for SynBioBeta 2018 by August 31. This year we have an expanded exhibit area that can hold 60 exhibitors, if you are interested in exhibiting at the conference please drop me a note by next Friday.

We’ve sold 191 free tickets so far for Synthetic Biology Week events, if you have not checked them out then you can do so here. Labcyte’s hosting two free awesome workshops on October 4th, you can learn how cell-free transcription-translation systems are a versatile platform for protein production within synthetic biology, and how the Echo Liquid Handler can reduce your experimental cycle time. On October 5th, visit Codexis’ HQ in Redwood City for an introduction to protein engineering and a lab tour that showcases their cutting-edge enzyme design technology.

Finally, check out these cool projects: LogicInk announced their Kickstarter to develop tattoo sensors that give you live feedback about your body and environment, and ZBiotics launched a crowdfunding campaign for the world’s 1st bioengineered probiotic drink.

Regards,
John

Pheronym awarded a $500,000 grant to expand nematode bio-remediation technology
Arvind Gupta’s Jiu Jitsu makes biotech move at Silicon Valley speed
ATUM receives patent to expand transposon technologies for protein development
BlueNalu raises $4.5 million to launch “cellular aquaculture”
Biological engineers discover new antibiotic candidates
This new biotech industry could pose a huge risk to fertilizer stocks
Ironing-free future? Scientists cotton on to benefits of man-made fibres
Bristol Diabetes spin-out acquired by Novo Nordisk for $800M
1 Million DNA shares: Cambridge nonprofit akin to science Airbnb approaches milestone

All the News

Correcting sickle cell–causing mutation with CRISPR-Cas9 genome editing (Press release)


Turning coffee waste into coffee cups – synthetic pathway converts mannose into lactic acid for the production of biodegradable plastics (Macquarie University)


A switch to turn fragrances on and off – Key to mass-producing beneficial plant compounds (Salk Institute for Biological Studies)


Environmentally friendly and sustainable alternatives to insecticides could save farmers millions of dollars (Virginia Tech)


Synthetic bacteria help treat phenylketonuria in mice (The Scientist)


This synthetic biology stock is soaring, but investors shouldn’t overlook a key risk (The Motley Fool)

Who’s Hiring?

Chief Technology Officer: Boost Biomes, South San Francisco, CA, US


Data Curator: Pivot Bio, Berkeley, CA


Scientist, Microbiologist: Pivot Bio, Berkeley, CA


Scientist/Senior Scientist, Microbial Formulation: Pivot Bio, RTP, North Carolina


Software Engineer: Pivot Bio, Berkeley, CA


To feature your job here, please get in touch

            
Copyright © %%current_year_YYYY%%, All rights reserved.

SynBioBeta
1547 Palos Verdes Mall, #411
Walnut Creek, CA 94597

About Us | Update Preferences | Unsubscribe | View email in your browser

Stay updated on the latest news in synthetic biology

Join our weekly newsletter

Sign up

Add comment

Job opportunities

More